Journal of Lipid Research, Vol. 24, 147-155, February 1983
Copyright © 1983 by Lipid Research, Inc.

Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia

John D. Brunzell , John J. Albers , Alan Chait , Scott M. Grundy , Elliott Groszek , and George B. McDonald

Division of Metabolism and Endocrinology, Division of Gastroenterology, and the Lipid Research Clinic of the University of Washington, Seattle, WA 98195, and the Veterans Administration Hospital and University of California, San Diego, CA 92161

Plasma lipoprotein concentration, composition, and size were evaluated in two common familial forms of hypertriglyceridemia and compared with those in normal subjects. The very low density lipoproteins (VLDL) were triglyceride-enriched in familial hypertriglyceridemia (triglyceride/apoprotein B ratio: 25.7 ± 8.9) as compared to normal (9.6 ± 12.2, P < 0.001) or familial combined hyperlipidemia (9.7 ± 3.3, P < 0.001). The diameter of VLDL was larger in familial hypertriglyceridemia (3.27 ± 0.28 pm) than in familial combined hyperlipidemia (2.87 ± 0.16 pm, P < 0.02). Although in familial hypertriglyceridemia VLDL tended to be larger, and in familial combined hyperlipidemia VLDL tended to be smaller than normal (3.08 ± 0.48 pm), neither of these differences were significant. While VLDL was normally distributed in the control population, the size was skewed to larger particles in familial hypertriglyceridemia with fewer small particles (P < 0.05) and skewed to smaller particles in familial combined hyperlipidemia with fewer large particles (P < 0.05). VLDL was reciprocally related to low density lipoproteins (LDL) in familial combined hyperlipidemia (r = -0.80 to -0.87) suggesting that the concentrations of these individual lipoprotein groups were somehow interrelated. There was no significant relationship between these two lipoprotein classes in familial hypertriglyceridemia or in normals. In familial combined hyperlipidemia, the apoprotein A-I/A-II ratio was below normal (P < 0.01) suggestive of low HDL₂ levels. This change in apoprotein composition was independent of VLDL or LDL concentration. In familial hypertriglyceridemia, high density lipoprotein (HDL) cholesterol was reduced (33% below mean normal) and HDL triglyceride was increased (by 46%), while the concentration of apoA-I and apoA-II was normal. VLDL triglyceride was inversely related to HDL cholesterol in familial hypertriglyceridemia (r = -0.74, P < 0.005), but not in familial combined hyperlipidemia. The large, triglyceride-enriched VLDL observed in familial hypertriglyceridemia is compatible with the reported increase in VLDL triglyceride synthesis seen in this disorder. The increase in VLDL apoprotein B synthesis previously reported in familial combined hyperlipidemia was associated with VLDL of normal composition. The changes in HDL cholesterol in these two disorders might reflect exchange of triglyceride between VLDL and HDL or could be related to transfer of surface components during the catabolism of VLDL. The reciprocal relationship between various components of VLDL and LDL seen in familial combined hyperlipidemia, but not in familial hypertriglyceridemia or in normal subjects, might provide some insight into the pathological abnormalities in these disorders. The differences between these two common familial forms of hypertriglyceridemia provide further support that they are distinct entities.—Brunzell, J. D., J. J. Albers, A. Chait, S. M. Grundy, E. Groszek, and G. B. McDonald. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.

Supplementary key words very low density lipoprotein • high density lipoprotein • apoprotein B

Submitted on September 4, 1981
Revised on July 21, 1982

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. D. Brunzell Hypertriglyceridemia N. Engl. J. Med., September 6, 2007; 357(10): 1009 - 1017. [Full Text] [PDF]

				M. C.G.J. Brouwers, N. Kono, M. M.J. van Greevenbroek, C. J.H. van der Kallen, A. J. Lusis, T. W.A. de Bruin, and R. M. Cantor Longitudinal Differences in Familial Combined Hyperlipidemia Quantitative Trait Loci. Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): e118 - e119. [Full Text] [PDF]

				A. Huertas-Vazquez, C. Aguilar-Salinas, A. J. Lusis, R. M. Cantor, S. Canizales-Quinteros, J. C. Lee, L. Mariana-Nunez, R.-M. L. Riba-Ramirez, A. Jokiaho, T. Tusie-Luna, et al. Familial Combined Hyperlipidemia in Mexicans: Association With Upstream Transcription Factor 1 and Linkage on Chromosome 16q24.1 Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1985 - 1991. [Abstract] [Full Text] [PDF]

				T. Y. Hui, S. S. Sheth, J. M. Diffley, D. W. Potter, A. J. Lusis, A. D. Attie, and R. A. Davis Mice Lacking Thioredoxin-interacting Protein Provide Evidence Linking Cellular Redox State to Appropriate Response to Nutritional Signals J. Biol. Chem., June 4, 2004; 279(23): 24387 - 24393. [Abstract] [Full Text] [PDF]

				M. C. Carr and J. D. Brunzell Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2601 - 2607. [Abstract] [Full Text] [PDF]

				T.B. Twickler, G.M. Dallinga-Thie, J.S. Cohn, and M.J. Chapman Elevated Remnant-Like Particle Cholesterol Concentration: A Characteristic Feature of the Atherogenic Lipoprotein Phenotype Circulation, April 27, 2004; 109(16): 1918 - 1925. [Full Text] [PDF]

				R. Mar, P. Pajukanta, H. Allayee, M. Groenendijk, G. Dallinga-Thie, R. M. Krauss, J. S. Sinsheimer, R. M. Cantor, T. W.A. de Bruin, and A. J. Lusis Association of the APOLIPOPROTEIN A1/C3/A4/A5 Gene Cluster With Triglyceride Levels and LDL Particle Size in Familial Combined Hyperlipidemia Circ. Res., April 16, 2004; 94(7): 993 - 999. [Abstract] [Full Text] [PDF]

				A.M. Georgieva, M.M.J. van Greevenbroek, R.M. Krauss, M.C.G.J. Brouwers, V.M.M.-J. Vermeulen, M.G. Robertus-Teunissen, C.J.H. van der Kallen, and T.W.A. de Bruin Subclasses of Low-Density Lipoprotein and Very Low-Density Lipoprotein in Familial Combined Hyperlipidemia: Relationship to Multiple Lipoprotein Phenotype Arterioscler. Thromb. Vasc. Biol., April 1, 2004; 24(4): 744 - 749. [Abstract] [Full Text] [PDF]

				R. P. Naoumova, S. A. Bonney, S. Eichenbaum-Voline, H. N. Patel, B. Jones, E. L. Jones, J. Amey, S. Colilla, C. K.Y. Neuwirth, R. Allotey, et al. Confirmed Locus on Chromosome 11p and Candidate Loci on 6q and 8p for the Triglyceride and Cholesterol Traits of Combined Hyperlipidemia Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2070 - 2077. [Abstract] [Full Text] [PDF]

				A. Soro, M. Jauhiainen, C. Ehnholm, and M.-R. Taskinen Determinants of low HDL levels in familial combined hyperlipidemia J. Lipid Res., August 1, 2003; 44(8): 1536 - 1544. [Abstract] [Full Text] [PDF]

				A. F. Ayyobi, S. H. McGladdery, M. J. McNeely, M. A. Austin, A. G. Motulsky, and J. D. Brunzell Small, Dense LDL and Elevated Apolipoprotein B Are the Common Characteristics for the Three Major Lipid Phenotypes of Familial Combined Hyperlipidemia Arterioscler. Thromb. Vasc. Biol., July 1, 2003; 23(7): 1289 - 1294. [Abstract] [Full Text] [PDF]

				M. W. Love, A. L. Craddock, B. Angelin, J. D. Brunzell, W. C. Duane, and P. A. Dawson Analysis of the Ileal Bile Acid Transporter Gene, SLC10A2, in Subjects With Familial Hypertriglyceridemia Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 2039 - 2045. [Abstract] [Full Text] [PDF]

				A. D. Attie, J. P. Kastelein, and M. R. Hayden Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis J. Lipid Res., November 1, 2001; 42(11): 1717 - 1726. [Abstract] [Full Text] [PDF]

				J. Pihlajamaki, M. Austin, K. Edwards, and M. Laakso A Major Gene Effect on Fasting Insulin and Insulin Sensitivity in Familial Combined Hyperlipidemia Diabetes, October 1, 2001; 50(10): 2396 - 2401. [Abstract] [Full Text]

				J. Q. Purnell, S. E. Kahn, R. S. Schwartz, and J. D. Brunzell Relationship of Insulin Sensitivity and ApoB Levels to Intra-abdominal Fat in Subjects With Familial Combined Hyperlipidemia Arterioscler. Thromb. Vasc. Biol., April 1, 2001; 21(4): 567 - 572. [Abstract] [Full Text] [PDF]

				M. Groenendijk, R. M. Cantor, T. W. A. De Bruin, and G. M. Dallinga-Thie New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia J. Lipid Res., February 1, 2001; 42(2): 188 - 194. [Abstract] [Full Text]

				H. Allayee, K. M. Dominguez, B. E. Aouizerat, R. M. Krauss, J. I. Rotter, J. Lu, R. M. Cantor, T. W. A. de Bruin, and A. J. Lusis Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia J. Lipid Res., February 1, 2000; 41(2): 245 - 252. [Abstract] [Full Text]

				B. E. Aouizerat, H. Allayee, R. M. Cantor, G. M. Dallinga-Thie, C. D. Lanning, T. W. A. de Bruin, A. J. Lusis, and J. I. Rotter Linkage of a Candidate Gene Locus to Familial Combined Hyperlipidemia : Lecithin:Cholesterol Acyltransferase on 16q Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2730 - 2736. [Abstract] [Full Text] [PDF]

				M. Groenendijk, R. M. Cantor, N. H. H. C. Blom, J. I. Rotter, T. W. A. de Bruin, and G. M. Dallinga-Thie Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia J. Lipid Res., June 1, 1999; 40(6): 1036 - 1044. [Abstract] [Full Text]

				J. Ribalta, J. Girona, J. C. Vallvé, A. E. La Ville, M. Heras, and L. Masana Vitamin A is linked to the expression of the AI-CIII-AIV gene cluster in familial combined hyperlipidemia J. Lipid Res., March 1, 1999; 40(3): 426 - 431. [Abstract] [Full Text]

				Y. Huang, X. Q. Liu, S. C. Rall Jr., J. M. Taylor, A. von Eckardstein, G. Assmann, and R. W. Mahley Overexpression and Accumulation of Apolipoprotein E as a Cause of Hypertriglyceridemia J. Biol. Chem., October 9, 1998; 273(41): 26388 - 26393. [Abstract] [Full Text] [PDF]

				E. M. Wijsman, J. D. Brunzell, G. P. Jarvik, M. A. Austin, A. G. Motulsky, and S. S. Deeb Evidence Against Linkage of Familial Combined Hyperlipidemia to the Apolipoprotein AI-CIII-AIV Gene Complex Arterioscler. Thromb. Vasc. Biol., February 1, 1998; 18(2): 215 - 226. [Abstract] [Full Text] [PDF]

				R. H. Knopp and X. Zhu Multiple Beneficial Effects of Estrogen on Lipoprotein Metabolism J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3952 - 3954. [Full Text] [PDF]

				J. Ribalta, A. E. LaVille, J. Girona, J. C. Vallve, and L. Masana Low plasma vitamin A concentrations in familial combined hyperlipidemia Clin. Chem., December 1, 1997; 43(12): 2379 - 2383. [Abstract] [Full Text] [PDF]

				E. Ehrenborg, S. M. Clee, S. N. Pimstone, P. W.A. Reymer, P. Benlian, C. F. Hoogendijk, H. J. Davis, N. Bissada, L. Miao, S. E. Gagne, et al. Ethnic Variation and In Vivo Effects of the -93t->g Promoter Variant in the Lipoprotein Lipase Gene Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2672 - 2678. [Abstract] [Full Text]

				P. Pajukanta, K. V.K. Porkka, M. Antikainen, M.-R. Taskinen, M. Perola, S. Murtomaki-Repo, S. Ehnholm, I. Nuotio, L. Suurinkeroinen, A.-T. Lahdenkari, et al. No Evidence of Linkage Between Familial Combined Hyperlipidemia and Genes Encoding Lipolytic Enzymes in Finnish Families Arterioscler. Thromb. Vasc. Biol., May 1, 1997; 17(5): 841 - 850. [Abstract] [Full Text]

				T. J. Aitman, I. F. Godsland, B. Farren, D. Crook, H. J. Wong, and J. Scott Defects of Insulin Action on Fatty Acid and Carbohydrate Metabolism in Familial Combined Hyperlipidemia Arterioscler. Thromb. Vasc. Biol., April 1, 1997; 17(4): 748 - 754. [Abstract] [Full Text]

				Y. B. de Rijke*, S. J.H. Bredie*, P. N.M. Demacker, J. M. Vogelaar, H. L.M. Hak-Lemmers, and A. F.H. Stalenhoef The Redox Status of Coenzyme Q10 in Total LDL as an Indicator of In Vivo Oxidative Modification: Studies on Subjects With Familial Combined Hyperlipidemia Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 127 - 133. [Abstract] [Full Text]

				M. C. Mahaney, J. Blangero, A. G. Comuzzie, J. L. VandeBerg, M. P. Stern, and J. W. MacCluer Plasma HDL Cholesterol, Triglycerides, and Adiposity : A Quantitative Genetic Test of the Conjoint Trait Hypothesis in the San Antonio Family Heart Study Circulation, December 1, 1995; 92(11): 3240 - 3248. [Abstract] [Full Text]

				M. Bertolotti, M. Concari, P. Loria, N. Abate, A. Pinetti, M. E. Guicciardi, and N. Carulli Effects of Different Phenotypes of Hyperlipoproteinemia and of Treatment With Fibric Acid Derivatives on the Rates of Cholesterol 7{alpha}-Hydroxylation in Humans Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1064 - 1069. [Abstract] [Full Text]

				B. D. Mitchell, C. G. Villalpando, B. A. Perez, M. S. Garcia, R. Valdez, and M. P. Stern Myocardial Infarction and Cardiovascular Risk Factors in Mexico City and San Antonio, Texas Arterioscler. Thromb. Vasc. Biol., June 1, 1995; 15(6): 721 - 725. [Abstract] [Full Text]

				J. E. Hokanson, R. M. Krauss, J. J. Albers, M. A. Austin, and J. D. Brunzell LDL Physical and Chemical Properties in Familial Combined Hyperlipidemia Arterioscler. Thromb. Vasc. Biol., April 1, 1995; 15(4): 452 - 459. [Abstract] [Full Text]